Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Beuselinck

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Acta Clinica Belgica|December 14, 2020
Equivocal evaluation of progressive disease in patients treated with immune checkpoint inhibitors: a challenge for clinical trials and biomarker researchAnastasios Kyriazoglou, Benoit Beuselinck
Acta Cardiologica|November 7, 2007
Think outside the heart! Case report of Lyme diseaseBenoit Beuselinck, Rik Willems
European Urology|July 30, 2021
Three Years After CARMENA: What Have We Learned?Eduard Roussel, Benoit Beuselinck, Maarten Albersen
Cancer Treatment Reviews|September 7, 2010
Sunitinib for the treatment of metastatic renal cell carcinomaStéphane Oudard, Benoit Beuselinck, Jasper Decoene, et al.
Acta Clinica Belgica|February 27, 2023
Systemic autoimmune rheumatic diseases as paraneoplastic phenomena: 3 illustrative case reports and narrative review of the literatureAnouck Poelman, Barbara Neerinckx, Benoit Beuselinck, et al.
Cancers|January 21, 2023
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular CarcinomaCedric Brackenier, Lisa Kinget, Sarah Cappuyns, et al.
Critical Reviews in Oncology/Hematology|August 5, 2009
Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical OncologyBenoit Beuselinck, Hans Wildiers, Wim Wynendaele, et al.
Expert Review of Anticancer Therapy|March 20, 2014
Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agentsYann-Alexandre Vano, Eric Tartour, Laure S Fournier, et al.
Clinical Genitourinary Cancer|January 22, 2013
Are tyrosine kinase inhibitors still active in patients with metastatic renal cell carcinoma previously treated with a tyrosine kinase inhibitor and everolimus? Experience of 36 patients treated in France in the RECORD-1 TrialAurore Blesius, Benoit Beuselinck, Christine Chevreau, et al.
Technology in Cancer Research & Treatment|July 17, 2025
Stereotactic Body Radiotherapy for Extracranial Oligometastatic Renal Cell Carcinoma: State of the Art and Future PerspectivesSander Vandaele, Maarten Albersen, Benoit Beuselinck, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Acta Clinica Belgica|December 14, 2020
Equivocal evaluation of progressive disease in patients treated with immune checkpoint inhibitors: a challenge for clinical trials and biomarker researchAnastasios Kyriazoglou, Benoit Beuselinck
Acta Cardiologica|November 7, 2007
Think outside the heart! Case report of Lyme diseaseBenoit Beuselinck, Rik Willems
European Urology|July 30, 2021
Three Years After CARMENA: What Have We Learned?Eduard Roussel, Benoit Beuselinck, Maarten Albersen
Cancer Treatment Reviews|September 7, 2010
Sunitinib for the treatment of metastatic renal cell carcinomaStéphane Oudard, Benoit Beuselinck, Jasper Decoene, et al.
Acta Clinica Belgica|February 27, 2023
Systemic autoimmune rheumatic diseases as paraneoplastic phenomena: 3 illustrative case reports and narrative review of the literatureAnouck Poelman, Barbara Neerinckx, Benoit Beuselinck, et al.
Cancers|January 21, 2023
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular CarcinomaCedric Brackenier, Lisa Kinget, Sarah Cappuyns, et al.
Critical Reviews in Oncology/Hematology|August 5, 2009
Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical OncologyBenoit Beuselinck, Hans Wildiers, Wim Wynendaele, et al.
Expert Review of Anticancer Therapy|March 20, 2014
Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agentsYann-Alexandre Vano, Eric Tartour, Laure S Fournier, et al.
Clinical Genitourinary Cancer|January 22, 2013
Are tyrosine kinase inhibitors still active in patients with metastatic renal cell carcinoma previously treated with a tyrosine kinase inhibitor and everolimus? Experience of 36 patients treated in France in the RECORD-1 TrialAurore Blesius, Benoit Beuselinck, Christine Chevreau, et al.
Technology in Cancer Research & Treatment|July 17, 2025
Stereotactic Body Radiotherapy for Extracranial Oligometastatic Renal Cell Carcinoma: State of the Art and Future PerspectivesSander Vandaele, Maarten Albersen, Benoit Beuselinck, et al.
Pageof 12